Overview
This exploratory study will focus on the development of the analyses of blood biomarkers to better understand the circulating biomarkers associated with cancer diagnosis, treatment efficacy and progressive disease
Eligibility
Inclusion Criteria:
- Adult (>18y)
- Owing a social security insurance
- Any solid cancer diagnosed by histopathology or cytology
- Patient with blood sampling required as per standard of care
- Informed consent signed
Exclusion Criteria:
- Refusal to participate
- No blood sampling required as per standard of care
- Hemoglobin < 7g/dl (< 9g/dl if respiratory or cardiovascular disease history)
- Heterologous blood transfusion in the last 48 hours
- Weight under 20 kg